--- title: "Pre-market hot trades in US stocks: Coupang pre-market down 7.37%; Coeur Mining pre-market up 7.06%" type: "News" locale: "en" url: "https://longbridge.com/en/news/285354487.md" description: "Coupang pre-market down 7.37%; Coeur Mining pre-market up 7.06%; Entravision Communications pre-market up 73.12%; EasyLink pre-market up 62.13%; Avalo Therapeutics pre-market up 46.49%" datetime: "2026-05-06T10:17:51.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/285354487.md) - [en](https://longbridge.com/en/news/285354487.md) - [zh-HK](https://longbridge.com/zh-HK/news/285354487.md) --- # Pre-market hot trades in US stocks: Coupang pre-market down 7.37%; Coeur Mining pre-market up 7.06% **Pre-market Hot Trades in US Stocks** Coupang pre-market down 7.37%. Based on recent key news: 1. On May 6, Coupang announced its financial report showing adjusted EBITDA plummeting 92% to $29 million, with gross margin dropping to 27%, leading to a more than 7% decline in stock price after hours. Total operating expenses exceeded quarterly revenue, active customer growth slowed, and the expansion of paid memberships decelerated, increasing market concerns over data breaches and platform controversies. 2. On May 6, the Korea Fair Trade Commission redefined Bom Kim as the actual controller of Coupang, replacing the recognition of corporate entity control. This move increased Bom Kim's governance responsibilities and intensified regulatory pressure, affecting stock performance. 3. On May 6, Coupang announced a $391 million buyback of 20.4 million shares and approved an additional $1 billion buyback plan in an attempt to boost market confidence, but the stock price continued to decline. The e-commerce industry faces slowing growth and regulatory pressure. Coeur Mining pre-market up 7.06%. Based on recent news, 1. On May 6, Coeur Mining released an announcement through the EDGAR system, disclosing the latest financial data and operational status. The announcement showed significant profit growth in the past quarter, exceeding market expectations. This news boosted investor confidence, driving the stock price up 7.06% in pre-market trading. The mining industry has performed strongly recently, with rising metal prices. **Top Gainers in Pre-market US Stocks** Entravision Communications pre-market up 73.12%. Based on recent key news: 1. On May 5, Entravision released its first-quarter financial report, showing GAAP earnings per share of $0.13 and revenue of $196.97 million, a year-on-year increase of 114.4%. This strong financial performance significantly boosted the stock price. Source: Entravision press release. 2. On May 5, Entravision's first-quarter operating income was $20.689 million, with pre-tax profit of $17.754 million and net profit of $12.36 million. These financial figures exceeded market expectations, further boosting investor confidence. Source: Reuters. 3. On May 5, Entravision's local advertising revenue grew by 6%, while national advertising revenue declined by 18%. Despite the decline in national advertising revenue, the overall financial performance remained strong, driving the stock price up. Source: Entravision press release. The advertising industry is facing structural adjustments and requires attention. Yidianxing pre-market up 62.13%, with no significant recent news. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation Avalo Therapeutics pre-market rose by 46.49%. Based on recent key news: 1. On May 6, Avalo Therapeutics announced that the LOTUS trial successfully reached its primary endpoint, leading to a rise in stock price. The company also announced a public offering, expecting to raise approximately $375 million, with the stock price rising 48.5% in after-hours trading. Source: Reuters 2. On May 5, Avalo Therapeutics priced a $375 million public offering at $17.75 per share. This move enhanced market confidence in the company's financial stability, driving the stock price up. Source: Benzinga 3. On May 6, Avalo Therapeutics' stock price rose 18% in regular trading, showing a strong long-term upward trend. Source: Benzinga The biotechnology industry has recently performed strongly, with significant capital inflows ### Related Stocks - [CPNG.US](https://longbridge.com/en/quote/CPNG.US.md) - [CDE.US](https://longbridge.com/en/quote/CDE.US.md) - [EVC.US](https://longbridge.com/en/quote/EVC.US.md) - [EZGO.US](https://longbridge.com/en/quote/EZGO.US.md) - [AVTX.US](https://longbridge.com/en/quote/AVTX.US.md) ## Related News & Research - [Coupang Director Kevin Warsh Resigns Following Fed Chair Confirmation](https://longbridge.com/en/news/286474920.md) - [Ethic Inc. Grows Stock Holdings in Coupang, Inc. $CPNG](https://longbridge.com/en/news/286056046.md) - [Coeur Mining presents balanced North American precious-metals portfolio after recent mine deals](https://longbridge.com/en/news/287056040.md) - [BUZZ-Silver miners fall on rising yields, stronger dollar](https://longbridge.com/en/news/286580214.md) - [South Korea's watchdog names Coupang founder as controlling entity](https://longbridge.com/en/news/284483971.md)